Advertisement
Person › Details
Francois Conquet (Prexton Therapeutics S.A.)
Conquet, Francois (Prexton Therapeutics 201207– CEO + founder)
Organisation | Prexton Therapeutics S.A. | |
Group | Lundbeck (Group) | |
Product | Parkinson drug | |
Record changed: 2021-10-26 |
Advertisement
More documents for Francois Conquet
- [1] Exciva GmbH. (10/26/21). "Press Release: Exciva Raises €9 Million in Series A Round Led by Andera Partners". Heidelberg....
- [2] H. Lundbeck A/S. (3/16/18). "Press Release: Lundbeck to Acquire Prexton Therapeutics Adding Foliglurax in Clinical Phase II to Its Pipeline of Innovative Treatments for Patients Suffering from Parkinson's Disease". Valby & Oss....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top